Cardiol Therapeutics Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Free Cash Flow -$17.4MTTM through 31 Dec 2025
Margins
| Current | |
|---|---|
| Gross Margin | 0.0% |
| Operating Margin | -43,570.9% |
| Net Margin | -42,939.2% |
Returns
-148.8%ROE
-112.6%ROA
Balance Sheet Health
Debt / Equity0.00x
Current Ratio4.16x
Net Debt-$21.3Mnet cash position
Cash & Equivalents$21.4M
Quality Metrics
Piotroski F-Score1 / 9
FCF Margin-30,319.0%
Earnings-Beat Rate50.0%
Multi-Year Trend
RevenueFY2021: $78.8K
Diluted EPSFY2023: $-0.44
Dividend
No dividend
Capital Allocation
Capex Intensity42.6%
Financials converted at 1.3695 from CAD.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.